IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations

References

• CarruthersACarruthersJColemanWPIIIMulticenter, randomized, phase III study of a single dose of incobotulinumtoxinA, free from complexing proteins, in the treatment of glabellar frown linesDermatol Surg201339455155823379292
   PubMed Web of Science ®Google Scholar
• HankeCWNarinsRSBrandtFA randomized, placebo-controlled, double-blind phase III trial investigating the efficacy and safety of incobotulinumtoxinA in the treatment of glabellar frown lines using a stringent composite endpointDermatol Surg201339689189923506308
   PubMed Web of Science ®Google Scholar
• ImhofMKühneUA Phase III study of incobotulinumtoxinA in the treatment of glabellar frown linesJ Clin Aesthet Dermatol2011410283422010053
   PubMedGoogle Scholar
• LeeJHParkJHLeeSKEfficacy and safety of incobotulinum toxin A in periocular rhytides and masseteric hypertrophy: side-by-side comparison with onabotulinum toxin AJ Dermatolog Treat201425432633023356833
   PubMed Web of Science ®Google Scholar
• Oliveira de MoraisOMatos Reis-FilhoEVilela PereiraLMartins GomesCAlvesGComparison of four botulinum neurotoxin type A preparations in the treatment of hyperdynamic forehead lines in men: a pilot studyJ Drugs Dermatol201211221621922270205
   PubMed Web of Science ®Google Scholar
• PragerWBeeEKHavermannIZschockeIOnset, longevity, and patient satisfaction with incobotulinumtoxinA for the treatment of glabellar frown lines: a single-arm, prospective clinical studyClin Interv Aging2013844945623650444
   PubMed Web of Science ®Google Scholar
• PragerWWissmüllerEKollhorstBWilliamsSZschockeIComparison of two botulinum toxin type A preparations for treating crow’s feet: a split-face, double-blind, proof-of-concept studyDermatol Surg201036Suppl 42155216021134046
   PubMed Web of Science ®Google Scholar
• SattlerGCallanderMJGrablowitzDNoninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown linesDermatol Surg201036Suppl 42146215421134045
   PubMed Web of Science ®Google Scholar
• CarruthersJALoweNJMenterMABOTOX Glabellar Lines I Study Group. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar linesJ Am Acad Dermatol200246684084912063480
   PubMed Web of Science ®Google Scholar
• CarruthersJDLoweNJMenterMAGibsonJEadieNBotox Glabellar Lines II Study Groupplacebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar linesPlast Reconstr Surg200311241089109812973229
   PubMed Web of Science ®Google Scholar
• LoweNJAscherBHeckmannMKumarCFraczekSEadieNBotox Facial Aesthetics Study TeamDouble-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow’s feetDermatol Surg200531325726215841623
   PubMed Web of Science ®Google Scholar
• AscherBRzanyBJGroverREfficacy and safety of botulinum toxin type A in the treatment of lateral crow’s feet: double-blind, placebo- controlled, dose-ranging studyDermatol Surg200935101478148619686365
   PubMed Web of Science ®Google Scholar
• Bocouture®Summary of Product CharacteristicsMerz Pharmaceuticals GmbHGermany2012
   Google Scholar
• Lantox Botulinum Toxin Type A [Homepage on the Internet]Lantox, Mедицина и косметология [Lantox, Health and Beauty] Available from: http://www.lantox.ruAccessed January 8, 2014 Russian
   Google Scholar
• WenzelRJonesDBorregoJAComparing two botulinum toxin type A formulations using manufacturers’ product summariesJ Clin Pharm Ther200732438740217635341
   PubMed Web of Science ®Google Scholar
• CarruthersAKaneMAFlynnTCThe convergence of medicine and neurotoxins: a focus on botulinum toxin type A and its application in aesthetic medicine – a global, evidence-based botulinum toxin consensus education initiative: part I: botulinum toxin in clinical and cosmetic practiceDermatol Surg2013393 Pt 249350923458294
   PubMed Web of Science ®Google Scholar
• First National Esthetic PortalBotulinum toxin in Russia – Review Available from: http://www.1nep.ru/en/articles/177070/Accessed March 10, 2015
   Google Scholar
• FrevertJXeomin: an innovative new botulinum toxin type AEur J Neurol200916Suppl 2111320002741
   PubMed Web of Science ®Google Scholar
• LeeJCYokotaKArimitsuHProduction of anti-neurotoxin antibody is enhanced by two subcomponents, HA1 and HA3b, of Clostridium botulinum type B 16S toxin-haemagglutininMicrobiology2005151Pt 113739374716272395
   PubMed Web of Science ®Google Scholar
• Solov’evMMTrezubovVNKudriavtsevaTDProtasevichAIRaadZShul’kinaNMEkspertnaia ésteticheskaia otsenka litsa [The expert esthetic evaluation of the face]Stomatologiia (Mosk)19947334246 Russian7846713
   PubMedGoogle Scholar
• CarruthersJFagienSMatarassoSLBotox Consensus GroupConsensus recommendations on the use of botulinum toxin type a in facial aestheticsPlast Reconstr Surg2004114Suppl 61S22S15507786
   PubMed Web of Science ®Google Scholar
• RaspaldoHBaspeyrasMBellityPConsensus GroupUpper- and mid-face anti-aging treatment and prevention using onabotulinumtoxin A: the 2010 multidisciplinary French consensus – part 1J Cosmet Dermatol2011101365021332914
   PubMed Web of Science ®Google Scholar
• RaspaldoHNiforosFRGassiaVConsensus GroupLower-face and neck antiaging treatment and prevention using onabotulinumtoxin A: the 2010 multidisciplinary French consensus – part 2J Cosmet Dermatol201110213114921649819
   PubMed Web of Science ®Google Scholar
• PoulainBTrevidicPClaveMClinical equivalence of conventional onabotulinumtoxinA (900 KDa) and incobotulinumtoxinA (neurotoxin free from complexing proteins – 150 KDa): 2012 multidisciplinary French consensus in aestheticsJ Drugs Dermatol201312121434144624301246
   PubMed Web of Science ®Google Scholar
• Leitlinie der Deutschen Dermatologischen GesellschaftÄsthetische Botulinumtoxin-Therapie [Guideline of the German Society of Dermatology. Aesthetic Botulinum Toxin Therapy]ImhofMPoddaMSommerB AWMF online2012 Available from: http://www.awmf.org/uploads/tx_szleitlinien/013-077l_S1_%C3%84sthetische_Botulinum-toxin_Therapie_2012-11.pdfAccessed March 10, 2015 German
   Google Scholar
• MostovaiaAIdeals of physical beauty in the prose of Russian women writers in the Soviet and post-Soviet eraTranscultural Studies2006–20072–3153171
   Google Scholar
• Gil-RoblesAReport by Mr Alvaro Gil-Robles, Commissioner for human rights, on his visits to the Russian FederationCouncil of Europe2005 Available from: https://wcd.coe.int/ViewDoc.jsp?id=846655Accessed January 12, 2014
   Google Scholar
• Cosmetics in RussiaRussian market for Botox and other minimally-invasive procedures grows 20% annually Available from: https://cos-meticsrussia.livejournal.com/2578.htmlAccessed January 12, 2014
   Google Scholar
• The American Society for Aesthetic Plastic SurgeryStatistics Available from: http://www.surgery.org/media/statisticsAccessed February 10, 2014
   Google Scholar
• CarruthersJFournierNKerscherMRuiz-AvilaJTrindade de AlmeidaARKaeuperGThe convergence of medicine and neurotoxins: a focus on botulinum toxin type A and its application in aesthetic medicine – a global, evidence-based botulinum toxin consensus education initiative: part II: incorporating botulinum toxin into aesthetic clinical practiceDermatol Surg2013393 Pt 251052523458295
   PubMed Web of Science ®Google Scholar
• LorencZPKenkelJMFagienSConsensus panel’s assessment and recommendations on the use of 3 botulinum toxin type A products in facial aestheticsAesthet Surg J201333Suppl 135S40S23515197
   PubMed Web of Science ®Google Scholar
• PragerWDifferential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown linesClin Pharmacol20135395223516136
   PubMedGoogle Scholar
• LeeJHParkJHLeeSKEfficacy and safety of incobotulinum toxin A in periocular rhytides and masseteric hypertrophy: side-by-side comparison with onabotulinum toxin AJ Dermatolog Treat201425432633023356833
   PubMed Web of Science ®Google Scholar
• CampanatiAGiuliodoriKMartinaEGiulianoAGanzettiGOffidaniAOnabotulinumtoxin type A (Botox®) versus incobotulinumtoxin type A (Xeomin®) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trialJ Neural Transm20141211212624052109
   PubMed Web of Science ®Google Scholar
• Moers-CarpiMDirschkaTFeller-HepptGA randomised, double-blind comparison of 20 units of onabotulinumtoxinA with 30 units of incobotulinumtoxinA for glabellar linesJ Cosmet Laser Ther201214629630323057624
   PubMed Web of Science ®Google Scholar
• PragerWRapplTPhase IV study comparing incobotulinumtoxinA and onabotulinumtoxinA using a 1:1.5 dose-conversion ratio for the treatment of glabellar frown linesJ Cosmet Dermatol201211426727123174049
   PubMed Web of Science ®Google Scholar
• CoxSEFinnJCSocial implications of hyperdynamic facial lines and patient satisfaction outcomesInt Ophthalmol Clin2005453132415970763
   PubMedGoogle Scholar
• FedokFGThe aging faceFacial Plast Surg19961221071159220725
   PubMedGoogle Scholar
• ShettyMKIADVL Dermatosurgery Task ForceGuidelines on the use of botulinum toxin type AIndian J Dermatol Venereol Leprol200874SupplS13S2218688099
   PubMed Web of Science ®Google Scholar
• SuryadevaraACUpdate on perioral cosmetic enhancementCurr Opin Otolaryngol Head Neck Surg200816434735118626254
   PubMed Web of Science ®Google Scholar
• FagienSRaspaldoHFacial rejuvenation with botulinum neurotoxin: an anatomical and experiential perspectiveJ Cosmet Laser Ther20079Suppl 1233117885883
   PubMedGoogle Scholar
• CarruthersJDGlogauRGBlitzerAFacial Aesthetics Consensus Group FacultyAdvances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies – consensus recommendationsPlast Reconstr Surg20081215 Suppl5S30S18449026
   PubMed Web of Science ®Google Scholar
• BeerKYohnMClosterJA double-blinded, placebo-controlled study of Botox for the treatment of subjects with chin rhytidsJ Drugs Dermatol20054441742216004014
   PubMedGoogle Scholar
• LoweNJYamauchiPCosmetic uses of botulinum toxins for lower aspects of the face and neckClin Dermatol2004221182215158540
   PubMed Web of Science ®Google Scholar
• LevyPMThe ‘Nefertiti lift’: a new technique for specific re-contouring of the jawlineJ Cosmet Laser Ther20079424925218236245
   PubMedGoogle Scholar
• GubanovaEIPanovaOSSanchezEARodinaMYStarovatovaPAEfficacy and safety of incobotulinumtoxinA for the treatment of platysmal bands of the aging neck: an open-label, prospective pilot studyJ Drugs Dermatol201312121461146624301249
   PubMed Web of Science ®Google Scholar
• KaneMANonsurgical treatment of platysma bands with injection of botulinum toxin a revisitedPlast Reconstr Surg2003112Suppl 5125S126S14504493
   PubMedGoogle Scholar
• MatarassoAMatarassoSLBrandtFSBellmanBBotulinum A exotoxin for the management of platysma bandsPlast Reconstr Surg2003112Suppl 5127S134S
   Google Scholar
• HirschRStierMComplications and their management in cosmetic dermatologyDermatol Clin2009274507520vii19850200
   PubMed Web of Science ®Google Scholar